APA (7th ed.) Citation

Chakraborty, D., Sharma, A., Mondal, S., Sheth, J., Sinha, T. K., Boral, S., . . . Maitra, R. Brolucizumab versus aflibercept for recalcitrant diabetic macular edema in Indian real-world scenario – The BRADIR study. Elsevier.

Chicago Style (17th ed.) Citation

Chakraborty, Debdulal, Ashish Sharma, Soumen Mondal, Jay Sheth, Tushar Kanti Sinha, Subhendu Boral, Angshuman Mukherjee, Ranabir Bhattacharya, and Ritobroto Maitra. Brolucizumab Versus Aflibercept for Recalcitrant Diabetic Macular Edema in Indian Real-world Scenario – The BRADIR Study. Elsevier.

MLA (9th ed.) Citation

Chakraborty, Debdulal, et al. Brolucizumab Versus Aflibercept for Recalcitrant Diabetic Macular Edema in Indian Real-world Scenario – The BRADIR Study. Elsevier.